Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Quality or quantity in the management of hereditary ovarian cancer risk: Is it really a trade-off?

Quality or quantity in the management of hereditary ovarian cancer risk: Is it really a trade-off? J Clin Oncol. 2005 Oct 01; 23(28):6817-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.